FDA Approves Prosthetic Arm

The agency OKs the first prosthetic arm controlled by neural signals from the user’s muscles.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The DEKA armDARPAThe US Food and Drug Administration (FDA) last week (May 9) green-lighted the sale of the DEKA Research and Development Corporation’s prosthetic arm—called “the Luke arm” by its creators—making it the first FDA-approved prosthetic arm with movements controlled by electrical signals sent from the user’s body—either from electrode attached to the muscles in the remaining part of the amputated limb or in the user’s feet. The New Hampshire-based company now seeks a manufacturer to be able to put the DARPA-funded product on the market.

“In comparison to commercially available prosthetics, the new arm offers powered shoulder movements and a wider range of wrist movements,” noted MIT Technology Review, referring to a study published last year. And data examined by the FDA as part of its products fast-track review process demonstrated that “approximately 90 percent of study participants were able to perform activities with the DEKA Arm System that they were not able to perform with their current prosthesis, such as using keys and locks, preparing food, feeding oneself, using zippers, and brushing and combing hair,” according to an agency press release.

“Think about our military personnel, who can be great beneficiaries of these devices: before DARPA made an investment in this area the best we could give back to ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours